Good potential just needs to demonstrate sales traction
APAS Clinical
In addition to the US, Thermo Fisher have recently been appointed distributor for the EU market.
In the latest ********* interview it was suggested further sale/s expected this calendar year. We’ll have to wait and see
APAS Pharma
Recently received $1.7m development funding from AstraZeneca and Thermo
Development expected end of this year and sales next year (given AstraZeneca are funding its development would expect they’ll be rolling out across their manufacturing sites - as suggested in that interview)
In addition to AstraZeneca, APAS being placed with another pharma company
APAS pharma is a new capability - could be very fruitful, but we’ll have to wait and see.
LBT Price at posting:
3.5¢ Sentiment: None Disclosure: Held
